We've upgraded AI Tools on TaxTMI with two powerful modes:
1. Basic • Quick overview summary answering your query with references• Category-wise results to explore all relevant documents on TaxTMI
2. Advanced • Includes everything in Basic • Detailed report covering: - Overview Summary - Governing Provisions [Acts, Notifications, Circulars] - Relevant Case Laws - Tariff / Classification / HSN - Expert views from TaxTMI - Practical Guidance with immediate steps and dispute strategy
• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.Help Us Improve - by giving the rating with each AI Result:
Appellate tribunal grants waiver and stay, ruling demand of duty and penalty unsustainable. The appellate tribunal ruled in favor of the assessee, granting waiver of pre-deposit and stay of recovery for the demand of duty and penalty. The ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Appellate tribunal grants waiver and stay, ruling demand of duty and penalty unsustainable.
The appellate tribunal ruled in favor of the assessee, granting waiver of pre-deposit and stay of recovery for the demand of duty and penalty. The tribunal found the demand of duty on medicaments sold to buyers, based on the transaction value, to be prima facie unsustainable under Rule 4 of the Central Excise Valuation Rules. Additionally, the tribunal granted waiver and stay of recovery for the penalty associated with physician's samples, as duty on those had already been paid by the assessee.
Issues: 1. Demand of duty on medicaments cleared as physician's samples. 2. Applicability of Rule 4 of the Central Excise Valuation Rules to goods sold to buyers. 3. Interpretation of the Hon'ble High Court's judgment in Indian Drugs Manufacturer's Association v. CCE. 4. Basis of valuation for goods sold and delivered at the time and place of removal. 5. Prima facie sustainability of demand of differential duty. 6. Waiver of pre-deposit and stay of recovery regarding demand of duty and penalty.
Analysis:
1. The appellate tribunal noted that the lower authorities confirmed a demand of duty on medicaments cleared as physician's samples, with the appellants having paid a portion of the duty. The rest of the demand was on medicaments sold to buyers. The authorities applied Rule 4 of the Central Excise Valuation Rules to both physician's samples and goods sold, citing a High Court judgment.
2. The tribunal examined the High Court's judgment in Indian Drugs Manufacturer's Association v. CCE, which discussed the valuation of physician's free samples under Section 4(1)(b) of the Central Excise Act read with the Valuation Rules. The tribunal specifically referred to para (20) of the judgment, which highlighted that for goods sold and delivered at the time and place of removal, the basis of valuation should be the transaction value at each removal.
3. Considering the facts of the present case where the goods were sold to customers, the tribunal concluded that the payment of duty on the transaction value aligns with Section 4(1)(a) of the Central Excise Act. Consequently, the demand of differential duty under Rule 4 was deemed prima facie unsustainable, leading to the grant of waiver of pre-deposit and stay of recovery for the duty on goods sold and the corresponding penalty.
4. As the duty on free samples of medicaments had already been paid by the assessee, the tribunal also granted waiver of pre-deposit and stay of recovery for the penalty associated with the samples. Ultimately, the tribunal ruled in favor of the assessee, ordering the waiver of pre-deposit and stay of recovery in relation to the dues adjudged against them.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.